Products – RETIMIX®
CURCUMA-PHYPHOLIPID 250 mg
BOSWELLIA-PHYPHOLIPID 250 mg
RETIMIX® is a food supplement with an innovative formula (Casperiva®) based on Turmeric (Curcuma longa) and Indian oli-banum (Boswellia serrata) complexed within phytosomes.
The patented technology of Eye Pharma
Casperiva®, a concentrated blend of synergistic active ingredients: curcuminoids and boswelic acids. Our patented system (Phytosome®) allows greater bioavailability of these active compounds.
Extracts of curcuminoid active ingredients (curcumin, demethoxicurcumin and bisdemethoxicurcumin) and boswellic acids belonging to the triterpenoid family, including AKBA (3-Acetyl-11-keto-beta-Boswellic Acid), the most well documented and active compound.
Curcuminoids and boswelic acids (AKBA) act synergistically to target chronic inflammation and pathogenic neoangiogenesis.
The specific characteristics of these active ingredients make them an ideal treatment to support drug therapies for eye inflammatory diseases with formation of new vessels.
The combination of curcuminoids and boswelic acids in Casperiva® allows their synergistic action to control the inflammatory response on several levels.
Casperiva® is an Eye Pharma SpA brand
Phytosome® is an Indena SpA brand
NEWS AND INSIGHTS
WET AGE-RELATED MACULAR DEGENERATION (AMD): PHARMACOLOGICAL THERAPIES (INTRAVITREAL INJECTIONS)
Intravitreal injections, performed by a qualified ophthalmologist, allow placing a specific drug directly into the space in the back of the eye called the vitreous cavity, near the retina …